This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceuticals Australia Pty Ltd. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations in Cancer Treatment by Tony Rowe
Introduction
Tony Rowe is an accomplished inventor based in Sandringham, Australia. He has made significant contributions to the field of cancer treatment, particularly focusing on therapies involving mutated KRAS or BRAF genes. His innovative approach aims to improve the lives of patients suffering from specific types of cancer.
Latest Patents
Tony Rowe holds a patent for a method of treating cancer in subjects with mutated KRAS or BRAF genes. The patent describes a method that involves administering an effective amount of an antibody or an antigen binding fragment that competes with SC104 for binding to the human colon cancer cell line Colo205. This groundbreaking invention has the potential to enhance treatment options for patients with these genetic mutations.
Career Highlights
Tony Rowe is currently associated with Teva Pharmaceuticals Australia Pty Ltd, where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in the fight against cancer.
Collaborations
Some of his notable coworkers include Norbert A Kienzle and Anthony Gerard Doyle. Their collaborative efforts contribute to the advancement of cancer treatment methodologies.
Conclusion
Tony Rowe's work in developing treatments for cancer involving mutated genes showcases his commitment to medical innovation. His contributions are vital in the ongoing battle against cancer, offering hope for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile